Table 6 The presurgery characteristic of patients in the two group underwent subretinal fluid drainage or without subretinal fluid drainage
From: The impact of the COVID-19 Pandemic on rhegmatogenous retinal detachment treatment patterns
| Â | Patients without subretinal fluid drainage | Patients underwent subretinal fluid drainage | ||||
|---|---|---|---|---|---|---|
The COVID-19 pandemic group(13) | The pre-COVID-19 group(28) | p | The COVID-19 pandemic group(11) | The pre-COVID-19 group(46) | p | |
age (mean, y) | 32 | 35.3 | 0.62 | 48.2 | 42.4 | 0.36 |
presurgery wait time (median, d) | 4.2 | 15.3 | 0.01 | 11.3 | 7.1 | 0.33 |
RRD-CD (n) | 1 | 0 | 0.31 | 2 | 5 | 0.61 |
PM (n) | 9 | 5 | 0.003 | 2 | 6 | 0.64 |
pseudophakia (n) | 1 | 3 | 1.0 | 0 | 3 | 1.0 |
PVR B-C (n) | 9 | 20 | 0.40 | 9 | 38 | 1.0 |
retinal breaks posterior to the equator (n) | 2 | 3 | 0.65 | 0 | 8 | 0.33 |
retinal breaks anterior to the equator (n) | 11 | 25 | 0.65 | 11 | 37 | 0.18 |
macular-off (n) | 10 | 14 | 0.17 | 9 | 31 | 0.48 |